Use of Electronic Health Record Data in Clinical Investigations; Draft Guidance for Industry
The Food and Drug Administration (FDA) has issued a draft guidance for industry "Use of Electronic Health Record Data in Clinical Investigations." The draft guidance is intended to assist sponsors, clinical investigators, contract research organizations, institutional review boards (IRBs), and other interested parties on the use of electronic health record (EHR) data in FDA-regulated clinical investigations. The guidance aims to facilitate use of electronic health record (EHR) data in clinical investigations and to promote the interoperability of EHRs and electronic systems supporting the clinical investigation.
Please see the Notice of Availability (NOA) for information on how to submit comments on the draft guidance.
No hay comentarios:
Publicar un comentario